Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shadia Jalal, MD
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Va Palo Alto Health Care System, Palo Alto, Ca
Palo Alto, California, United States
Recruiting - Jesse Brown Va Medical Center, Chicago, Il
Chicago, Illinois, United States
Not, yet, recruiting - Richard L. Roudebush Va Medical Center, Indianapolis, in
Indianapolis, Indiana, United States
Shadia Jalal, MDRecruiting - Robley Rex Va Medical Center, Louisville, Ky
Louisville, Kentucky, United States
Not, yet, recruiting - Va Ann Arbor Healthcare System, Ann Arbor, Mi
Ann Arbor, Michigan, United States
Not, yet, recruiting - Minneapolis Va Health Care System, Minneapolis, Mn
Minneapolis, Minnesota, United States
Not, yet, recruiting - Omaha Va Nebraska-Western Iowa Health Care System, Omaha, Ne
Omaha, Nebraska, United States
Not, yet, recruiting - Salisbury W.G. (bill) Hefner Va Medical Center, Salisbury, Nc
Salisbury, North Carolina, United States
Recruiting - Corporal Michael J. Crescenz Va Medical Center, Philadelphia, Pa
Philadelphia, Pennsylvania, United States
Recruiting - Va Pittsburgh Healthcare System University Drive Division, Pittsburgh, Pa
Pittsburgh, Pennsylvania, United States
Recruiting - Michael E. Debakey Va Medical Center, Houston, Tx
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Feb 2026
- Primary completion
- 31 Dec 2029
- Completion
- 31 Dec 2030
- Last update posted
- 11 Mar 2026
- Registered enrollment
- 166
- Registry id
- NCT06681220
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.